Source comparison
Morning vs Night: The Receptor Availability Window That Matters
Morning dosing upon waking targets the body's most robust natural GH pulse. Cortisol awakening response (CAR). The sharp rise in cortisol 30–45 minutes after waking. Directly stimulates hypothalamic GHRH release, priming pituitary somatotrophs for maximum resp
This comparison does not assign a generated winner or score.
- Morning dosing upon waking targets the body's most robust natural GH pulse. Cortisol awakening response (CAR). The sharp rise in cortisol 30–45 minutes after waking. Directly stimulates hypothalamic GHRH release, priming pituitary somatotrophs for maximum responsiveness. When CJC-1295 no DAC is administered within this window (ideally 15–30 minutes post-waking), it synchronizes with peak endogenous GHRH activity.
- Night dosing is more complex. The largest nocturnal GH pulse occurs 60–90 minutes into Stage 3 slow-wave sleep, not at bedtime. Dosing immediately before bed means the peptide's 30-minute active window expires before the natural pulse begins. The correct night dosing protocol. If you choose this timing. Requires administration 90–120 minutes before your planned sleep onset, allowing the peptide's peak activity to coincide with the onset of slow-wave sleep.
- Here's the honest answer: night dosing works in controlled research settings where sleep onset is predictable and participants fall asleep within 10–15 minutes of lying down. In real-world application, variable sleep latency (the time it takes to fall asleep) creates mistiming. If you dose 90 minutes before bed but take 45 minutes to fall asleep, you've missed the pulse window entirely.
- Morning dosing eliminates this variable. The cortisol awakening response occurs whether you feel rested or not. It's a hard-coded circadian event. This reliability makes morning administration the default recommendation for CJC-1295 no DAC protocols.